In Vitro and In Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183Randy S. Schrecengost, Charles D. Smith|Journal of Pharmacology and Experimental Therapeutics|2018Cited by 16